The first evidence of the relationship between ApoC-III and ASCVD risk comes from a study by Pollin et al. [16] which demonstrated that carriers of a rare APOC3 null-mutation have lower TG levels and a lower coronary calcium score. The gene discussed is APOC3; the disease is atherosclerosis.